A study from Ann & Robert H. Lurie Children's Hospital of Chicago found a potential link between GLP-1 weight-loss and diabetes medications and nutritional deficiencies in children.
Drugs like Ozempic or Wegovy, i.e. GLP-1-based drugs, have fundamentally changed how obesity is treated. They have been shown all over the world to be able to significantly reduce weight in people who are not helped by any other methods. And they have also been used to treat children for several years. However, a new American study shows that doctors should start paying more attention to children.